The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Change in tumor microenvironment and PD-L1 expression with rucaparib treatment in triple-negative breast cancer.
 
Ritika Halder
No Relationships to Disclose
 
Nitish Bhamidipati
No Relationships to Disclose
 
Alexi Kiss
No Relationships to Disclose
 
Walaa Aldhahri
No Relationships to Disclose
 
Sima Ehsani
No Relationships to Disclose
 
Jennifer Margaret Segar
No Relationships to Disclose
 
Nova Foster
No Relationships to Disclose
 
Pavani Chalasani
Consulting or Advisory Role - Atossa Genetics; bioTheranostics; Gilead Sciences; Lilly; OncoSec; Puma Biotechnology
Research Funding - Amgen (Inst); BioAtla (Inst); Carrick Therapeutics (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Phoenix Molecular Designs (Inst); Radius Health (Inst); Ventana Medical Systems (Inst); Zentalis (Inst)